Schaeffer's Top Stock Picks for '25

Biotech Stock Hits 2-Year Low as Vaccine Sales Decline

BioNTech reported lower-than-expected second-quarter revenue

Deputy Editor
Aug 7, 2023 at 11:05 AM
facebook X logo linkedin


BioNTech SE (NASDAQ:BNTX) is sinking to two-year lows today, after plunging Covid vaccine sales weighed on the company's second-quarter results. The biotech name reported narrower-than-expected losses of 79 cents per share alongside a revenue miss, with the company reducing its drug development as well. 

At last glance, BNTX was down 9.4% at $96.45, and on the short sell restricted (SSR) list. Before today, the $110 level was keeping a cap on gains, as well as overhead pressure from the stock's 80-day moving average. Year-to-date, the equity is down 35.5%. 

BioNTech stock's typically quiet options pits have seen 4.1 times the average daily options volume already, with 2,539 calls and 3,311 puts exchanged so far. The August 95 puts is the most active contract, with new positions being opened there. 

Analysts have yet to chime in on the results. Of the 17 in coverage, 11 carry a "buy" or better rating on BNTX, with six a tepid "hold." The 12-month consensus price target of $164.56 is a 68.8% premium to current levels. 

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?